C-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling

Barbara Peruzzi, Alfredo Cappariello, Andrea Del Fattore, Nadia Rucci, Fabrizio De Benedetti, Anna Teti

Research output: Contribution to journalArticlepeer-review


Interleukin-6 (IL-6) and c-Src impair osteoblast maturation in vitro and in vivo. Given the similar effects of these factors, they are likely to establish a functional loop to maintain osteoblasts in a less mature status. Here we describe a pathway whereby c-Src stimulates IL-6 expression through the STAT3 factor, which, in response to IL-6 induces insulin-like growth factor 5 (IGFBP5), a c-Src activating factor that amplifies this loop only in immature osteoblasts. In contrast, in mature osteoblasts, IGFBP5 is enhanced by Runx2, but is no longer able to stimulate c-Src activation, as this tyrosine kinase at this stage is downregulated. We find that the IGFBP5 produced by osteoblasts stimulates osteoclastogenesis and bone resorption, acting as an osteoblast-osteoclast coupling factor. Finally, we demonstrate that the integrated actions of c-Src, IL-6 and IGFBP5 also have a role in vivo. We conclude that this pathway is relevant for bone metabolism, both in physiological and in pathological conditions.

Original languageEnglish
Article number630
JournalNature Communications
Publication statusPublished - 2012

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Chemistry(all)
  • Physics and Astronomy(all)


Dive into the research topics of 'C-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling'. Together they form a unique fingerprint.

Cite this